NCT03878524 2024-03-04
Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME Trial
OHSU Knight Cancer Institute
Phase 1 Terminated
OHSU Knight Cancer Institute
Roswell Park Cancer Institute
National Institutes of Health Clinical Center (CC)
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
M.D. Anderson Cancer Center
National Institutes of Health Clinical Center (CC)
HaEmek Medical Center, Israel
Pfizer